Patrick Arbuthnot

5.4k total citations · 1 hit paper
128 papers, 3.7k citations indexed

About

Patrick Arbuthnot is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Patrick Arbuthnot has authored 128 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 59 papers in Epidemiology and 35 papers in Genetics. Recurrent topics in Patrick Arbuthnot's work include RNA Interference and Gene Delivery (70 papers), Hepatitis B Virus Studies (57 papers) and Virus-based gene therapy research (32 papers). Patrick Arbuthnot is often cited by papers focused on RNA Interference and Gene Delivery (70 papers), Hepatitis B Virus Studies (57 papers) and Virus-based gene therapy research (32 papers). Patrick Arbuthnot collaborates with scholars based in South Africa, United States and Germany. Patrick Arbuthnot's co-authors include Abdullah Ely, Kristie Bloom, Michael C. Kew, Fiona T. van den Berg, Marc S. Weinberg, Carol Crowther, Alexio Capovilla, Naazneen Moolla, Mohube Betty Maepa and Sergio Carmona and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Patrick Arbuthnot

125 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Self-amplifying RNA vaccines for infectious diseases

2020 316 citations Kristie Bloom, Fiona T. van den Berg et al. Gene Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Arbuthnot South Africa	34	2.5k	1.6k	753	644	606	128	3.7k
Patricia L. Marion United States	30	1.8k 0.7×	2.0k 1.3×	1.2k 1.6×	557 0.9×	657 1.1×	57	3.9k
Stacy M. Horner United States	34	2.7k 1.1×	870 0.6×	602 0.8×	182 0.3×	506 0.8×	61	4.4k
Zhongtian Qi China	27	1.2k 0.5×	599 0.4×	413 0.5×	260 0.4×	518 0.9×	136	2.6k
John McLauchlan United Kingdom	31	1.4k 0.6×	1.8k 1.1×	1.5k 1.9×	414 0.6×	295 0.5×	79	3.8k
Patrick R. Romano United States	21	1.8k 0.7×	830 0.5×	761 1.0×	208 0.3×	176 0.3×	26	3.2k
Catherine H. Wu United States	31	3.3k 1.3×	558 0.4×	483 0.6×	1.8k 2.8×	364 0.6×	100	4.3k
Seng-Lai Tan United States	17	1.0k 0.4×	1.1k 0.7×	1.2k 1.6×	186 0.3×	252 0.4×	20	2.6k
Cécile Voisset France	27	1.2k 0.5×	1.3k 0.8×	1.4k 1.9×	212 0.3×	188 0.3×	57	3.3k
Reiko Hirai Japan	18	1.5k 0.6×	570 0.4×	352 0.5×	163 0.3×	494 0.8×	41	3.3k
Stephen R. Yant United States	30	2.7k 1.1×	423 0.3×	178 0.2×	1.8k 2.8×	829 1.4×	47	3.8k

Countries citing papers authored by Patrick Arbuthnot

Since Specialization

Citations

This map shows the geographic impact of Patrick Arbuthnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Arbuthnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Arbuthnot more than expected).

Fields of papers citing papers by Patrick Arbuthnot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Arbuthnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Arbuthnot. The network helps show where Patrick Arbuthnot may publish in the future.

Co-authorship network of co-authors of Patrick Arbuthnot

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Arbuthnot. A scholar is included among the top collaborators of Patrick Arbuthnot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Arbuthnot. Patrick Arbuthnot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ely, Abdullah, et al.. (2025). Long-term inhibition of Hepatitis B virus gene expression by a primary microrna expressing ancestral adeno-associated viral vector. Virology Journal. 22(1). 41–41. 3 indexed citations

Bloom, Kristie, Abdullah Ely, Mohube Betty Maepa, & Patrick Arbuthnot. (2024). Bridging gene therapy and next-generation vaccine technologies. Gene Therapy. 32(1). 4–7. 2 indexed citations

Arbuthnot, Patrick, et al.. (2022). Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases. Gene Therapy. 32(1). 8–15. 5 indexed citations

Arbuthnot, Patrick, et al.. (2022). Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics. Genes. 13(11). 1941–1941. 7 indexed citations

Delhove, Juliette, Suzanne M. K. Buckley, Dany Perocheau, et al.. (2017). Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice. Scientific Reports. 7(1). 41874–41874. 7 indexed citations

Scott, Tristan, Buhle Moyo, Mohube Betty Maepa, et al.. (2017). ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells. Scientific Reports. 7(1). 7401–7401. 54 indexed citations

Berg, Fiona T. van den, John J. Rossi, Patrick Arbuthnot, & Marc S. Weinberg. (2016). Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations. Molecular Therapy — Nucleic Acids. 5. e278–e278. 5 indexed citations

Ely, Abdullah & Patrick Arbuthnot. (2015). Differing prospects for the future of using gene therapy to treat infections with hepatitis B virus and hepatitis C virus.. PubMed. 20(109). 137–43. 8 indexed citations

Crowther, Carol, et al.. (2013). Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes. Antiviral Therapy. 19(4). 363–373. 13 indexed citations

10.

Saayman, Sheena, Patrick Arbuthnot, & Marc S. Weinberg. (2010). Effective Pol III-Expressed Long Hairpin RNAs Targeted to Multiple Unique Sites of HIV-1. Methods in molecular biology. 629. 157–172. 7 indexed citations

11.

Islam, Rafique Ul, et al.. (2010). The Synthesis of Substituted Piperazine-cholesterol Conjugates for use as Components of Nucleic Acid Transfection Lipoplexes †. South African Journal of Chemistry. 63(1). 88–94.

12.

Arbuthnot, Patrick. (2010). Harnessing RNA interference for the treatment of viral infections. Drug News & Perspectives. 23(6). 341–341. 15 indexed citations

13.

Arbuthnot, Patrick, Abdullah Ely, & Marc S. Weinberg. (2009). Hepatic Delivery of RNA Interference Activators for Therapeutic Application. Current Gene Therapy. 9(2). 91–103. 13 indexed citations

14.

Liu, Jie, Li Li, Xianxing Li, et al.. (2009). Increased expression of ErbB‐2 in liver is associated with hepatitis B × antigen and shorter survival in patients with liver cancer. International Journal of Cancer. 125(8). 1894–1901. 35 indexed citations

15.

Scholefield, Janine, et al.. (2009). Design of RNAi Hairpins for Mutation-Specific Silencing of Ataxin-7 and Correction of a SCA7 Phenotype. PLoS ONE. 4(9). e7232–e7232. 48 indexed citations

16.

Arbuthnot, Patrick. (2008). Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World Journal of Gastroenterology. 14(11). 1670–1670. 26 indexed citations

17.

Weinberg, Marc S., et al.. (2006). Silencing of HIV-1 Subtype C Primary Isolates by Expressed Small Hairpin RNAs Targeted to gag. AIDS Research and Human Retroviruses. 22(5). 401–410. 9 indexed citations

18.

Carmona, Sergio, Abdullah Ely, Carol Crowther, et al.. (2005). Effective Inhibition of HBV Replication in Vivo by Anti-HBx Short Hairpin RNAs. Molecular Therapy. 13(2). 411–421. 86 indexed citations

19.

Lian, Zhaorui, Jie Liu, Jingbo Pan, et al.. (2001). A Cellular Gene Up–Regulated by Hepatitis B Virus-Encoded X Antigen Promotes Hepatocellular Growth and Survival. Hepatology. 34(1). 146–157. 44 indexed citations

20.

Weinberg, Marc S., et al.. (2000). In Situ Demonstration of Inhibitory Effects of Hammerhead Ribozymes That Are Targeted to the Hepatitis Bx Sequence in Cultured Cells. Biochemical and Biophysical Research Communications. 268(3). 728–733. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact